Integrity Alliance LLC. Acquires Shares of 4,315 Colgate-Palmolive Company $CL

Key Points

• Integrity Alliance LLC has acquired a new stake in Colgate-Palmolive, purchasing 4,315 shares valued at approximately $404,000 during the first quarter.
• Colgate-Palmolive recently reported earnings of $0.92 EPS, surpassing analyst estimates, with revenue of $5.11 billion for the quarter.
• The company will pay a quarterly dividend of $0.52 to shareholders on November 14, reflecting an annualized yield of 2.5%.

Integrity Alliance LLC. acquired a new stake in Colgate-Palmolive Company (NYSE:CL - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 4,315 shares of the company's stock, valued at approximately $404,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Cornerstone Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 1.2% in the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock valued at $847,000 after purchasing an additional 110 shares during the period. Aberdeen Wealth Management LLC increased its position in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock valued at $1,877,000 after acquiring an additional 125 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO increased its position in shares of Colgate-Palmolive by 4.0% in the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock valued at $317,000 after acquiring an additional 130 shares during the last quarter. Continuum Advisory LLC grew its holdings in Colgate-Palmolive by 17.2% during the fourth quarter. Continuum Advisory LLC now owns 893 shares of the company's stock worth $81,000 after purchasing an additional 131 shares during the period. Finally, KFG Wealth Management LLC grew its holdings in Colgate-Palmolive by 1.5% during the first quarter. KFG Wealth Management LLC now owns 8,835 shares of the company's stock worth $828,000 after purchasing an additional 131 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $83.35 on Friday. The stock has a market capitalization of $67.37 billion, a PE ratio of 23.41, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35. The company's 50-day moving average is $85.95 and its 200-day moving average is $89.55. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1 year low of $82.29 and a 1 year high of $106.26.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. During the same quarter in the prior year, the firm earned $0.91 EPS. The business's revenue was up 1.0% on a year-over-year basis. Equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.5%. Colgate-Palmolive's payout ratio is currently 58.43%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. UBS Group reduced their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. JPMorgan Chase & Co. cut their price target on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Citigroup lowered their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Barclays boosted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research report on Tuesday, July 15th. Finally, Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $98.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.